RxDoctor Payments Data

Dallas Mullock, DO

Family Medicine · Maryville, MONPI 1134504012

Payments from drug & device makers

$1,125in general payments, 2019–2025

Across 60 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$539
  • Lilly USA, LLC$187
  • Kvk-tech, Inc.$70
  • Amgen$59
  • Pfizer$57
  • Johnson & Johnson$50
  • plus $163 from 9 others

What the payments were for

  • Food & beverage$1,125100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,125 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$134,413
Medicare patients
197
Services billed
2,832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide53$54,224
OzempicSemaglutide45$42,689
JardianceEmpagliflozin26$27,556
FarxigaDapagliflozin Propanediol20$21,891
XareltoRivaroxaban12$15,704
EliquisApixaban16$15,097
TrulicityDulaglutide13$12,674
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$12,321
Tresiba Flextouch U-100Insulin Degludec13$6,824
Breo ElliptaFluticasone/Vilanterol12$6,450
ShingrixVaricella-Zoster Ge/As01b/Pf18$4,035
Dexlansoprazole DrDexlansoprazole13$2,767
Lantus SolostarInsulin Glargine,hum.Rec.Anlog32$2,247
Pantoprazole Sodium152$2,168
Duloxetine Hcl83$1,855

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$187$66,89766 claims
Boehringer IngelheimJardiance$14$27,55626 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$22$22,80643 claims
Johnson & JohnsonXarelto$50$15,70412 claims
PfizerEliquis$57$15,09716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Maryville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →